Table 1. Characteristics of healthy subjects and patients with NSCLC.
| Healthy controls (n=11) | NSCLC patients (n=50) | P-value | |
|---|---|---|---|
| Age | 66 (46–74) | 64 (43–83) | 0.894 |
| Sex (M/F) | 5/6 | 24/26 | 0.917 |
| BMI | 25.4 (22.4–28.9) | 21.9 (14.8–64.2) | 0.017 |
| Albumin (g l−1) | 43 (41–46) | 40 (28–44) | <0.001 |
| White cell count (109 l−1) | 6.7 (4.1–8.4) | 9.21 (5.1–23.5) | <0.001 |
| C-reactive protein (mg l−1) | <6 (<6–<6) | 26 (6–207) | <0.001 |
| IL-6 (pg ml−1) | <2 (<2–<2) | 13 (<2–103) | <0.001 |
| SIL-6R (ng ml−1) | 16.1 (14.9–24.2) | 18.8 (7.8–46.0) | 0.291 |
| Sgp130 (ng ml−1) | 234 (175–290) | 298 (227–448) | <0.001 |
| sTNF-RII (ng ml−1) | 1.5 (1.2–7.5) | 2.9 (1.5–6.8) | 0.001 |
| IL-1Ra (pg ml−1) | 286 (129–368) | 539 (132–2129) | <0.001 |
| IL-8 (pg ml−1) | <10 (<10–<10) | 13.9 (<10–118) | <0.001 |
Median (range).